DONEGAN MICHAEL C

PrivateCIK: 1627810
Location

BOCA RATON, FL

DONEGAN MICHAEL C (Vice President Finance) sold 16.7% of their position (910.00 shares) of THERAPEUTICSMD, INC. on the open market

Open‑market sale worth $4.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderDONEGAN MICHAEL CCIK 1627810
IssuerTHERAPEUTICSMD, INC.CIK 25743
Officer· Vice President Finance
Since Aug 2019
-910.00
Net shares
Net seller
$4.3K
Total sold
1
Open market trades
0B · 1S
9
Total transactions
3.48K acquired · 4.39K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+2.30K

Price / share

Trade value

% of position

115.7%
12/6/2022
1.99K4.29K

Common Stock

Direct
M · Option Exercise

Shares

+380.00

Price / share

Trade value

% of position

8.9%
12/6/2022
4.29K4.67K

Common Stock

Direct
M · Option Exercise

Shares

+534.00

Price / share

Trade value

% of position

11.4%
12/6/2022
4.67K5.20K

Common Stock

Direct
M · Option Exercise

Shares

+262.00

Price / share

Trade value

% of position

5.0%
12/6/2022
5.20K5.46K

Common Stock

Direct
S · Sale

Shares

910.00

Price / share

$4.78

Trade value

$4.35K

% of position

16.7%
12/6/2022
5.46K4.55K
Total

Net shares

+2.57K

Net value

-$4.35K

Derivative Transactions4

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

2.30K shares

Shares

2.30K

Strike price

0.00

Held after

0.00

Exercisable

12/6/2022

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

380.00 shares

Shares

380.00

Strike price

0.00

Held after

380.00

Exercisable

12/6/2022

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

534.00 shares

Shares

534.00

Strike price

0.00

Held after

1.07K

Exercisable

12/6/2022

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

262.00 shares

Shares

262.00

Strike price

0.00

Held after

519.00

Exercisable

12/6/2022
DONEGAN MICHAEL C — Insider Transaction (Form 4) Filed Dec 9, 2022 | Finecho